A detailed history of Wells Fargo & Company transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 14,379 shares of KYMR stock, worth $716,936. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,379
Previous 13,058 10.12%
Holding current value
$716,936
Previous $524,000 18.13%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$29.85 - $39.42 $39,431 - $52,073
1,321 Added 10.12%
14,379 $429,000
Q1 2024

May 10, 2024

BUY
$22.9 - $43.57 $51,937 - $98,816
2,268 Added 21.02%
13,058 $524,000
Q4 2023

Feb 09, 2024

SELL
$10.97 - $26.84 $279,548 - $683,963
-25,483 Reduced 70.25%
10,790 $274,000
Q3 2023

Nov 13, 2023

SELL
$13.9 - $23.88 $234,743 - $403,285
-16,888 Reduced 31.77%
36,273 $504,000
Q2 2023

Aug 15, 2023

BUY
$22.4 - $34.92 $243,801 - $380,069
10,884 Added 25.74%
53,161 $1.22 Million
Q1 2023

May 12, 2023

BUY
$24.84 - $38.75 $999,561 - $1.56 Million
40,240 Added 1975.45%
42,277 $1.25 Million
Q4 2022

Feb 13, 2023

SELL
$19.57 - $30.92 $28,767 - $45,452
-1,470 Reduced 41.92%
2,037 $50,000
Q3 2022

Nov 14, 2022

SELL
$20.91 - $34.27 $118,266 - $193,831
-5,656 Reduced 61.73%
3,507 $77,000
Q2 2022

Aug 12, 2022

SELL
$14.13 - $42.55 $131,465 - $395,885
-9,304 Reduced 50.38%
9,163 $180,000
Q1 2022

May 16, 2022

SELL
$35.3 - $64.68 $384,734 - $704,947
-10,899 Reduced 37.11%
18,467 $782,000
Q4 2021

Feb 14, 2022

SELL
$49.91 - $65.56 $305,249 - $400,964
-6,116 Reduced 17.24%
29,366 $1.87 Million
Q3 2021

Nov 15, 2021

BUY
$47.8 - $66.66 $1.63 Million - $2.27 Million
34,052 Added 2381.26%
35,482 $2.08 Million
Q2 2021

Aug 16, 2021

BUY
$31.08 - $51.95 $16,814 - $28,104
541 Added 60.85%
1,430 $69,000
Q1 2021

May 13, 2021

SELL
$35.64 - $85.46 $352,764 - $845,883
-9,898 Reduced 91.76%
889 $34,000
Q4 2020

Feb 09, 2021

BUY
$28.07 - $87.83 $302,791 - $947,422
10,787 New
10,787 $669,000

Others Institutions Holding KYMR

About Kymera Therapeutics, Inc.


  • Ticker KYMR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,705,800
  • Market Cap $2.73B
  • Description
  • Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...
More about KYMR
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.